In a report released today, Scott Siefers from Piper Sandler maintained a Buy rating on Fifth Third Bancorp (FITB – Research Report), with a ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

Piper Sandler’s price objective ... from $16.00 to $18.00 and gave the company a “neutral” rating in a research report on Monday, October 21st. Barclays boosted their price target on shares ...

ChampionX Corp (CHX) stock saw a modest uptick, ending the day at $31.21 which represents a slight increase of $2.06 or 7.07% from the prior close of $29.15. The stock opened at $29.52 and touched a ...

AirSculpt Technologies (NASDAQ:AIRS – Free Report) had its price target lowered by Piper Sandler ... the 3rd quarter. Barclays PLC now owns 19,100 shares of the company’s stock valued at ...

Piper Sandler adjusted its outlook on Charles Schwab Corp (BVMF:SCHW34). (NYSE: SCHW) shares, increasing the price target to $78 from $70 while maintaining a Neutral rating. The decision followed ...

Barclays (LON:BARC) made adjustments to its outlook on Nutrien shares (NYSE:NTR), downgrading the stock rating from ...